SCHEMBL5017555

SCHEMBL5017555

O=C(NCc1ccc(N2C3CCCC2CC3)c(C(F)(F)F)c1)Nc1cccc2c1cnn2C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5018080 0.92 TRPV1 (0.68) TRPV1
SCHEMBL5022679 0.90 TRPV1 (0.65) TRPV1
SCHEMBL5024546 0.90 TRPV1 (0.65) TRPV1
SCHEMBL5026121 0.82 TRPV1 (1.00) TRPV1
SCHEMBL5018061 0.76 TRPV1 (0.69) TRPV1
SCHEMBL5018076 0.73 TRPV1 (0.52) TRPV1
SCHEMBL2723125 0.72 TRPV1 (0.66) TRPV1
SCHEMBL5015985 0.71 TRPV1 (1.00) TRPV1
SCHEMBL5024577 0.71 TRPV1 (0.65) TRPV1
SCHEMBL2725143 0.70 TRPV1 (0.66) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660455-B1 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ABBOTT LAB (US) 2008-10-15 EP claimed